Urinary coenzyme Q10 as a diagnostic biomarker and predictor of remission in a patient with ADCK4-associated Glomerulopathy: a case report

AarF domain-containing kinase 4 (ADCK4)-associated glomerulopathy is a mitochondrial nephropathy caused by mutations in the ADCK4 gene, which disrupt coenzyme Q10 biosynthesis. We report the case of a 25-year-old female patient with ADCK4-associated glomerulopathy presenting with proteinuria (and wi...

Full description

Saved in:

Bibliographic Details
Published in:	BMC nephrology Vol. 22; no. 1; p. 11
Main Authors:	Zhang, Yan, Liao, Xiaohua, Jiang, Yupeng, Lv, Xin, Yu, Yue, Dai, Qin, Ao, Liyun, Tao, Lijian, Peng, Zhangzhe
Format:	Journal Article
Language:	English
Published:	England BioMed Central Ltd 07-01-2021 BioMed Central BMC
Subjects:	ADCK4 mutation Biological markers Biomarker Biomarkers Biopsy Care and treatment Case Report Case studies Coenzyme Q10 Creatinine Diagnosis Drug dosages Edema Genes Glomerulonephritis Health aspects Kidney diseases Mitochondria Mitochondrial diseases Mutation Nephrology Nephropathy Neuromuscular diseases Patients Prognosis Proteins Proteinuria Regression (Disease) Remission Remission (Medicine) Supplements Ultrasonic imaging Urine China Biomarker Case report Coenzyme Q10 ADCK4 mutation Proteinuria
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	AarF domain-containing kinase 4 (ADCK4)-associated glomerulopathy is a mitochondrial nephropathy caused by mutations in the ADCK4 gene, which disrupt coenzyme Q10 biosynthesis. We report the case of a 25-year-old female patient with ADCK4-associated glomerulopathy presenting with proteinuria (and with no additional systemic symptoms). A known missense substitution c.737G > A (p.S246N) and a novel frameshift c.577-600del (p.193-200del) mutation were found. We followed the patient for 24 months during supplementation with coenzyme Q10 (20 mg/kg/d - 30 mg/kg/d) and describe the clinical course. In addition, we measured serum and urine coenzyme Q10 levels before and after coenzyme Q10 supplementation and compared them with those of healthy control subjects. The patient's urinary coenzyme Q10 to creatinine ratio was higher than that of healthy controls before coenzyme Q10 supplementation, but decreased consistently with proteinuria after coenzyme Q10 supplementation. Although the use of urinary coenzyme Q10 as a diagnostic biomarker and predictor of clinical remission in patients with ADCK4-associated glomerulopathy should be confirmed by larger studies, we recommend measuring urinary coenzyme Q10 in patients with isolated proteinuria of unknown cause, since it may provide a diagnostic clue to mitochondrial nephropathy.
AbstractList	BACKGROUNDAarF domain-containing kinase 4 (ADCK4)-associated glomerulopathy is a mitochondrial nephropathy caused by mutations in the ADCK4 gene, which disrupt coenzyme Q10 biosynthesis. CASE PRESENTATIONWe report the case of a 25-year-old female patient with ADCK4-associated glomerulopathy presenting with proteinuria (and with no additional systemic symptoms). A known missense substitution c.737G > A (p.S246N) and a novel frameshift c.577-600del (p.193-200del) mutation were found. We followed the patient for 24 months during supplementation with coenzyme Q10 (20 mg/kg/d - 30 mg/kg/d) and describe the clinical course. In addition, we measured serum and urine coenzyme Q10 levels before and after coenzyme Q10 supplementation and compared them with those of healthy control subjects. The patient's urinary coenzyme Q10 to creatinine ratio was higher than that of healthy controls before coenzyme Q10 supplementation, but decreased consistently with proteinuria after coenzyme Q10 supplementation. CONCLUSIONSAlthough the use of urinary coenzyme Q10 as a diagnostic biomarker and predictor of clinical remission in patients with ADCK4-associated glomerulopathy should be confirmed by larger studies, we recommend measuring urinary coenzyme Q10 in patients with isolated proteinuria of unknown cause, since it may provide a diagnostic clue to mitochondrial nephropathy. Abstract Background AarF domain-containing kinase 4 (ADCK4)-associated glomerulopathy is a mitochondrial nephropathy caused by mutations in the ADCK4 gene, which disrupt coenzyme Q10 biosynthesis. Case presentation We report the case of a 25-year-old female patient with ADCK4-associated glomerulopathy presenting with proteinuria (and with no additional systemic symptoms). A known missense substitution c.737G > A (p.S246N) and a novel frameshift c.577-600del (p.193-200del) mutation were found. We followed the patient for 24 months during supplementation with coenzyme Q10 (20 mg/kg/d – 30 mg/kg/d) and describe the clinical course. In addition, we measured serum and urine coenzyme Q10 levels before and after coenzyme Q10 supplementation and compared them with those of healthy control subjects. The patient’s urinary coenzyme Q10 to creatinine ratio was higher than that of healthy controls before coenzyme Q10 supplementation, but decreased consistently with proteinuria after coenzyme Q10 supplementation. Conclusions Although the use of urinary coenzyme Q10 as a diagnostic biomarker and predictor of clinical remission in patients with ADCK4-associated glomerulopathy should be confirmed by larger studies, we recommend measuring urinary coenzyme Q10 in patients with isolated proteinuria of unknown cause, since it may provide a diagnostic clue to mitochondrial nephropathy. AarF domain-containing kinase 4 (ADCK4)-associated glomerulopathy is a mitochondrial nephropathy caused by mutations in the ADCK4 gene, which disrupt coenzyme Q10 biosynthesis. Although the use of urinary coenzyme Q10 as a diagnostic biomarker and predictor of clinical remission in patients with ADCK4-associated glomerulopathy should be confirmed by larger studies, we recommend measuring urinary coenzyme Q10 in patients with isolated proteinuria of unknown cause, since it may provide a diagnostic clue to mitochondrial nephropathy. Background AarF domain-containing kinase 4 (ADCK4)-associated glomerulopathy is a mitochondrial nephropathy caused by mutations in the ADCK4 gene, which disrupt coenzyme Q10 biosynthesis. Case presentation We report the case of a 25-year-old female patient with ADCK4-associated glomerulopathy presenting with proteinuria (and with no additional systemic symptoms). A known missense substitution c.737G > A (p.S246N) and a novel frameshift c.577-600del (p.193-200del) mutation were found. We followed the patient for 24 months during supplementation with coenzyme Q10 (20 mg/kg/d – 30 mg/kg/d) and describe the clinical course. In addition, we measured serum and urine coenzyme Q10 levels before and after coenzyme Q10 supplementation and compared them with those of healthy control subjects. The patient’s urinary coenzyme Q10 to creatinine ratio was higher than that of healthy controls before coenzyme Q10 supplementation, but decreased consistently with proteinuria after coenzyme Q10 supplementation. Conclusions Although the use of urinary coenzyme Q10 as a diagnostic biomarker and predictor of clinical remission in patients with ADCK4-associated glomerulopathy should be confirmed by larger studies, we recommend measuring urinary coenzyme Q10 in patients with isolated proteinuria of unknown cause, since it may provide a diagnostic clue to mitochondrial nephropathy. Background AarF domain-containing kinase 4 (ADCK4)-associated glomerulopathy is a mitochondrial nephropathy caused by mutations in the ADCK4 gene, which disrupt coenzyme Q10 biosynthesis. Case presentation We report the case of a 25-year-old female patient with ADCK4-associated glomerulopathy presenting with proteinuria (and with no additional systemic symptoms). A known missense substitution c.737G > A (p.S246N) and a novel frameshift c.577-600del (p.193-200del) mutation were found. We followed the patient for 24 months during supplementation with coenzyme Q10 (20 mg/kg/d - 30 mg/kg/d) and describe the clinical course. In addition, we measured serum and urine coenzyme Q10 levels before and after coenzyme Q10 supplementation and compared them with those of healthy control subjects. The patient's urinary coenzyme Q10 to creatinine ratio was higher than that of healthy controls before coenzyme Q10 supplementation, but decreased consistently with proteinuria after coenzyme Q10 supplementation. Conclusions Although the use of urinary coenzyme Q10 as a diagnostic biomarker and predictor of clinical remission in patients with ADCK4-associated glomerulopathy should be confirmed by larger studies, we recommend measuring urinary coenzyme Q10 in patients with isolated proteinuria of unknown cause, since it may provide a diagnostic clue to mitochondrial nephropathy. Keywords: ADCK4 mutation, Coenzyme Q10, Proteinuria, Biomarker, Case report AarF domain-containing kinase 4 (ADCK4)-associated glomerulopathy is a mitochondrial nephropathy caused by mutations in the ADCK4 gene, which disrupt coenzyme Q10 biosynthesis. We report the case of a 25-year-old female patient with ADCK4-associated glomerulopathy presenting with proteinuria (and with no additional systemic symptoms). A known missense substitution c.737G > A (p.S246N) and a novel frameshift c.577-600del (p.193-200del) mutation were found. We followed the patient for 24 months during supplementation with coenzyme Q10 (20 mg/kg/d - 30 mg/kg/d) and describe the clinical course. In addition, we measured serum and urine coenzyme Q10 levels before and after coenzyme Q10 supplementation and compared them with those of healthy control subjects. The patient's urinary coenzyme Q10 to creatinine ratio was higher than that of healthy controls before coenzyme Q10 supplementation, but decreased consistently with proteinuria after coenzyme Q10 supplementation. Although the use of urinary coenzyme Q10 as a diagnostic biomarker and predictor of clinical remission in patients with ADCK4-associated glomerulopathy should be confirmed by larger studies, we recommend measuring urinary coenzyme Q10 in patients with isolated proteinuria of unknown cause, since it may provide a diagnostic clue to mitochondrial nephropathy.
ArticleNumber	11
Audience	Academic
Author	Tao, Lijian Peng, Zhangzhe Liao, Xiaohua Jiang, Yupeng Dai, Qin Ao, Liyun Yu, Yue Zhang, Yan Lv, Xin
Author_xml	– sequence: 1 givenname: Yan surname: Zhang fullname: Zhang, Yan organization: Department of Nephrology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China – sequence: 2 givenname: Xiaohua surname: Liao fullname: Liao, Xiaohua organization: Department of Nephrology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China – sequence: 3 givenname: Yupeng surname: Jiang fullname: Jiang, Yupeng organization: Department of Nephrology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China – sequence: 4 givenname: Xin surname: Lv fullname: Lv, Xin organization: Department of Nephrology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China – sequence: 5 givenname: Yue surname: Yu fullname: Yu, Yue organization: Department of Nephrology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China – sequence: 6 givenname: Qin surname: Dai fullname: Dai, Qin organization: Department of Nephrology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China – sequence: 7 givenname: Liyun surname: Ao fullname: Ao, Liyun organization: Department of Nephrology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China – sequence: 8 givenname: Lijian surname: Tao fullname: Tao, Lijian organization: Department of Nephrology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China – sequence: 9 givenname: Zhangzhe surname: Peng fullname: Peng, Zhangzhe email: pengzhangzhe@csu.edu.cn organization: Department of Nephrology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China. pengzhangzhe@csu.edu.cn
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/33413146$$D View this record in MEDLINE/PubMed
BookMark	eNptUtFuFCEUnZga267-gA-GxJe-TIWBgcEHk82qtbGJMbHP5C4Du6yzsMKsZv0Ev9q73VpbYwhwA-ce7rmc0-oopuiq6jmj54x18lVhTdc1NW0ozoZ2tXpUnTChWN1wqY_uxcfVaSkrSpnqBH1SHXMuGGdCnlS_rnOIkHfEJhd_7taOfGaUQCFA-gCLmMoYLJmHtIb81WUCsSeb7Ppgx5RJ8iS7dSglpEhCxKQNjMHFkfwI45JM384-ihpKSTbA6HpyMaS1y9shIWy5e414C8Uhxybl8Wn12MNQ3LPbfVJdv3_3Zfahvvp0cTmbXtW2lXysW86saIFKXLXyXPTecealUhjaubOgGw-dV1L7eeO17R2zmuKVd5JzyyfV5YG3T7AymxxQ2s4kCObmIOWFgYyqB2fmLZdcM9lJDsJyNu-aFjTnWom2kxqQ682Ba7Odr11vUXqG4QHpw5sYlmaRvhulNNNaIMHZLUFO37aujAbbad0wQHRpW0wjlETZ-zom1ct_oKu0zRFbtUehE6ju1F_UAlBAiD7hu3ZPaqaypa0WlGpEnf8HhaPH77RoMx_w_EFCc0iwOZWSnb_TyKjZu9Ec3GjQjebGjWZfy4v73blL-WM__hs4ytwh
CitedBy_id	crossref_primary_10_3389_fped_2022_938863
Cites_doi	10.1007/s10545-014-9749-9 10.1002/biof.155 10.1002/biof.5520090205 10.1097/MD.0000000000008880 10.1016/j.neurol.2016.07.003 10.3390/jcm6040037 10.1186/s12881-017-0392-9 10.1172/JCI69000 10.1007/s00467-018-4083-3 10.1126/science.aac7516 10.1007/s00467-017-3657-9 10.1681/ASN.2014121240 10.1159/000013406 10.1016/j.bbrc.2018.10.102 10.1007/s00467-017-3590-y
ContentType	Journal Article
Copyright	COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2020
Copyright_xml	– notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2020
DBID	NPM AAYXX CITATION 3V. 7QP 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PIMPY PQEST PQQKQ PQUKI 7X8 5PM DOA
DOI	10.1186/s12882-020-02208-7
DatabaseName	PubMed CrossRef ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts ProQuest_Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Publicly Available Content Database (Proquest) (PQ_SDU_P3) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals
DatabaseTitle	PubMed CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic Publicly Available Content Database PubMed
Database_xml	– sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1471-2369
EndPage	11
ExternalDocumentID	oai_doaj_org_article_b5363916863a4c31b825a9339745869a A650594009 10_1186_s12882_020_02208_7 33413146
Genre	Journal Article Report Case Study
GeographicLocations	China
GeographicLocations_xml	– name: China
GroupedDBID	--- -A0 0R~ 23N 2WC 3V. 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AAWTL ABUWG ACGFO ACGFS ACIHN ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK IAO IHR INH INR ITC KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB AAYXX CITATION 7QP 7XB 8FK AZQEC DWQXO K9. PQEST PQUKI 7X8 5PM
ID	FETCH-LOGICAL-c563t-531c45a06c4597f34dfe31f67734dcbeca92fa8f769fb2f9cde1c90dcbfe633c3
IEDL.DBID	RPM
ISSN	1471-2369
IngestDate	Tue Oct 22 15:12:46 EDT 2024 Tue Sep 17 20:44:03 EDT 2024 Fri Oct 25 08:33:44 EDT 2024 Thu Oct 10 17:34:14 EDT 2024 Tue Nov 19 20:41:23 EST 2024 Tue Nov 12 22:50:56 EST 2024 Thu Nov 21 22:15:59 EST 2024 Sat Sep 28 08:29:45 EDT 2024
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Biomarker Case report Coenzyme Q10 ADCK4 mutation Proteinuria
Language	English
License	Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c563t-531c45a06c4597f34dfe31f67734dcbeca92fa8f769fb2f9cde1c90dcbfe633c3
Notes	ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3
OpenAccessLink	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791994/
PMID	33413146
PQID	2478820987
PQPubID	44769
PageCount	1
ParticipantIDs	doaj_primary_oai_doaj_org_article_b5363916863a4c31b825a9339745869a pubmedcentral_primary_oai_pubmedcentral_nih_gov_7791994 proquest_miscellaneous_2476563536 proquest_journals_2478820987 gale_infotracmisc_A650594009 gale_infotracacademiconefile_A650594009 crossref_primary_10_1186_s12882_020_02208_7 pubmed_primary_33413146
PublicationCentury	2000
PublicationDate	2021-01-07
PublicationDateYYYYMMDD	2021-01-07
PublicationDate_xml	– month: 01 year: 2021 text: 2021-01-07 day: 07
PublicationDecade	2020
PublicationPlace	England
PublicationPlace_xml	– name: England – name: London
PublicationTitle	BMC nephrology
PublicationTitleAlternate	BMC Nephrol
PublicationYear	2021
Publisher	BioMed Central Ltd BioMed Central BMC
Publisher_xml	– name: BioMed Central Ltd – name: BioMed Central – name: BMC
References	E Park (2208_CR14) 2017; 32 MA Desbats (2208_CR9) 2015; 38 K Lolin (2208_CR15) 2017; 18 M Stańczyk (2208_CR12) 2018; 33 F Kurogouchi (2208_CR3) 1998; 18 S Ashraf (2208_CR4) 2013; 123 E Korkmaz (2208_CR5) 2016; 27 F Wang (2208_CR10) 2017; 32 C Feng (2208_CR6) 2017; 96 C Tranchant (2208_CR2) 2016; 172 T Nakamura (2208_CR13) 1999; 9 RN Lightowlers (2208_CR1) 2015; 349 J Yang (2208_CR7) 2018; 506 CM Quinzii (2208_CR8) 2011; 37 D Yubero (2208_CR11) 2017; 6
References_xml	– volume: 38 start-page: 145 issue: 1 year: 2015 ident: 2208_CR9 publication-title: J Inherit Metab Dis doi: 10.1007/s10545-014-9749-9 contributor: fullname: MA Desbats – volume: 37 start-page: 361 issue: 5 year: 2011 ident: 2208_CR8 publication-title: Biofactors doi: 10.1002/biof.155 contributor: fullname: CM Quinzii – volume: 9 start-page: 111 year: 1999 ident: 2208_CR13 publication-title: Biofactors doi: 10.1002/biof.5520090205 contributor: fullname: T Nakamura – volume: 96 issue: 47 year: 2017 ident: 2208_CR6 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000008880 contributor: fullname: C Feng – volume: 172 start-page: 524 year: 2016 ident: 2208_CR2 publication-title: Rev Neurol (Paris) doi: 10.1016/j.neurol.2016.07.003 contributor: fullname: C Tranchant – volume: 6 start-page: 37 issue: 4 year: 2017 ident: 2208_CR11 publication-title: J Clin Med doi: 10.3390/jcm6040037 contributor: fullname: D Yubero – volume: 18 start-page: 28 issue: 1 year: 2017 ident: 2208_CR15 publication-title: BMC Med Genet doi: 10.1186/s12881-017-0392-9 contributor: fullname: K Lolin – volume: 123 start-page: 5179 issue: 12 year: 2013 ident: 2208_CR4 publication-title: J Clin Invest doi: 10.1172/JCI69000 contributor: fullname: S Ashraf – volume: 33 start-page: 2383 issue: 12 year: 2018 ident: 2208_CR12 publication-title: Pediatr Nephrol doi: 10.1007/s00467-018-4083-3 contributor: fullname: M Stańczyk – volume: 349 start-page: 1494 issue: 6255 year: 2015 ident: 2208_CR1 publication-title: Science doi: 10.1126/science.aac7516 contributor: fullname: RN Lightowlers – volume: 32 start-page: 1547 issue: 9 year: 2017 ident: 2208_CR14 publication-title: Pediatr Nephrol doi: 10.1007/s00467-017-3657-9 contributor: fullname: E Park – volume: 27 start-page: 63 issue: 1 year: 2016 ident: 2208_CR5 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2014121240 contributor: fullname: E Korkmaz – volume: 18 start-page: 551 issue: 6 year: 1998 ident: 2208_CR3 publication-title: Am J Nephrol doi: 10.1159/000013406 contributor: fullname: F Kurogouchi – volume: 506 start-page: 444 issue: 3 year: 2018 ident: 2208_CR7 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2018.10.102 contributor: fullname: J Yang – volume: 32 start-page: 1181 issue: 7 year: 2017 ident: 2208_CR10 publication-title: Pediatr Nephrol doi: 10.1007/s00467-017-3590-y contributor: fullname: F Wang
SSID	ssj0017840
Score	2.2801318
Snippet	AarF domain-containing kinase 4 (ADCK4)-associated glomerulopathy is a mitochondrial nephropathy caused by mutations in the ADCK4 gene, which disrupt coenzyme... Background AarF domain-containing kinase 4 (ADCK4)-associated glomerulopathy is a mitochondrial nephropathy caused by mutations in the ADCK4 gene, which... BACKGROUNDAarF domain-containing kinase 4 (ADCK4)-associated glomerulopathy is a mitochondrial nephropathy caused by mutations in the ADCK4 gene, which disrupt... Abstract Background AarF domain-containing kinase 4 (ADCK4)-associated glomerulopathy is a mitochondrial nephropathy caused by mutations in the ADCK4 gene,...
SourceID	doaj pubmedcentral proquest gale crossref pubmed
SourceType	Open Website Open Access Repository Aggregation Database Index Database
StartPage	11
SubjectTerms	ADCK4 mutation Biological markers Biomarker Biomarkers Biopsy Care and treatment Case Report Case studies Coenzyme Q10 Creatinine Diagnosis Drug dosages Edema Genes Glomerulonephritis Health aspects Kidney diseases Mitochondria Mitochondrial diseases Mutation Nephrology Nephropathy Neuromuscular diseases Patients Prognosis Proteins Proteinuria Regression (Disease) Remission Remission (Medicine) Supplements Ultrasonic imaging Urine
SummonAdditionalLinks	– databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBZtDqWX0qYvt0lRodBDEbEt69Xb5tVAaaG0gd6ErAcNJHbwZg_pT8ivzozlXWJ6yKUXYzwSSJqRZ0aa-YaQD3VyLY91YnWjBGtiKZiOoWXCVbrVOkY3Apie_FTff-vDI4TJ2ZT6wpiwDA-cF26vFVxicqiW3DWeVy24NA68cLCDhZYmm0alXDtT0_2BAr9lnSKj5d4S_sJgSaKrhJmlmqmZGhrR-v_9J99RSvOAyTsa6PgpeTKZjnSRh_yMPIjdNnn0bbocf05uTocxuZb6PnZ_ry8i_VGV1C2poyEH1EFHivn2GJIzUNcFejlgd_C7aZ_ogLXf8PSMnnXQaYJcpXhUSxeHB18b5iZmxkC_nPcXcVid91jT-PoztPegEGm-g3hBTo-Pfh2csKnUAvNC8isGO9E3wpUSnkYl3oQUeZWkUvDqgc_OAFd1UtKktk7Gh1h5UwIpRcm55y_JVtd38TWhHnyk2rRKBryBrUuTvG90ULqSrgxBFOTTeuXtZUbUsKMnoqXNfLLAJzvyyaqC7CNzNi0RDXv8ADJiJxmx98lIQT4iay3uWeCfd1PqAQwY0a_sAsxUgRXiTUF2Zi1h2f2cvBYOO-31pa2xAgHMU8Ng32_I2BPj17rYr8Y2YDhzGGdBXmVZ2kyJoyEBCqsgaiZlsznPKd3ZnxEJXCmD2M5v_scivSWPa4zXweMltUO2roZV3CUPl2H1btxbtwlDJkI priority: 102 providerName: Directory of Open Access Journals
Title	Urinary coenzyme Q10 as a diagnostic biomarker and predictor of remission in a patient with ADCK4-associated Glomerulopathy: a case report
URI	https://www.ncbi.nlm.nih.gov/pubmed/33413146 https://www.proquest.com/docview/2478820987 https://search.proquest.com/docview/2476563536 https://pubmed.ncbi.nlm.nih.gov/PMC7791994 https://doaj.org/article/b5363916863a4c31b825a9339745869a
Volume	22
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELboHhAXxJvAsjISEgeUbRonfnAr3V1WQotAsBI3y_EDKrVJlW4Py0_gVzPjJFUjblyiKPZIdmbGnrFnviHkTR5MxXwe0rwQZVr4rEyld1VampmspPTeRADTy2_i8w95do4wOeWQCxOD9m21PK1X69N6-SvGVm7WdjrEiU2_XC2EUAhpO52QCdiGg4veXx0IcFmG7BjJp1tYgMGIRC8Jk0plimX3GK7d0eg92IwiZv-_K_PB1jQOmzzYhy4ekPu9AUnn3UAfkju-fkTuXvVX5I_Jn-s2pthS2_j69-3a06-zjJotNdR1YXVASDHrHgNzWmpqRzctkoP3TZtAW6wAh2dodFkDUQ-8SvHAls7PFp-K1PQs9Y5-XDVr3-5WDVY2vn0P_S1si7S7iXhCri_Ovy8u077gQmpLzm5S0EdblCbj8FQisMIFz2aBCwGvFrhtFPBWBsFVqPKgrPMzqzJoCp4zZtlTclQ3tX9OqAVPKVeV4A7vYfNMBWsL6YSccZM5Vybk3fDn9abD1dDRH5FcdyzTwDIdWaZFQj4gc_Y9ERM7fmjan7qXDF2VjGMaseTMFJbNKnB-jWJgcBWl5Mok5C2yVqPmAv-s6RMQYMCIgaXnYKyWWCdeJeR41BN-ux03D8Khe43f6hzrEMA8JQz29b4ZKTGKrfbNLvYB85nBOBPyrJOl_ZQGkUyIGEnZaM7jFlCPiAfeq8OL_6Z8Se7lGKqDJ0vimBzdtDv_iky2bncSzyhOoob9BUK8KdA
link.rule.ids	230,315,729,782,786,866,887,2106,27933,27934,53800,53802
linkProvider	National Library of Medicine
linkToHtml	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZokYAL70eggJGQOKB0kzixHW7LtmVRuxWIVuJmOY4NK-0mq2z3UH4Cv5oZJ1ltxK2XKMp4JDvz2Z6x50HI-8TpgtnEhUkqsjC1URZKWxZhpmNZSGmt9glMpz_E-U95dIxpcrI-FsY77ZtiflgtlofV_Lf3rVwtzaj3Ext9m02EyDGl7WiP3Ib5GkW9kd5dHggwWvr4GMlHa1iCQY1EOwnDSmWIhfcYrt5e7d3ZjnzW_v_X5p3Naeg4ubMTnTy44Rgekvud6knHLfkRuWWrx-TOrLtcf0L-XjY-OJea2lZ_rpeWfo8jqtdU07J1yANGivH66NLTUF2VdNUgO9jttHa0wdpxePpG5xUwdSlbKR710vHR5DQNdQcGW9Ivi3ppm82ixprI15-gvYENlbZ3GE_J5cnxxWQadqUaQpNxdhXCTDZppiMOz1w4lpbOsthxIeDVAE50DqiQTvDcFYnLTWljk0dAcpYzZtgzsl_VlX1BqAEbK8kLwUu8wU2i3BmTylLImOuoLLOAfOwlplZtRg7lLRnJVStqBaJWXtRKBOQzCnXbErNp-w9180t18lBFxjgGIEvOdGpYXIDZrHMGqlqaSZ7rgHxASCic8yB3o7vQBegwZs9SY1BzM6wwnwfkYNASfrsZkntQqW6tWKsEKxjAOCV09t2WjJzo_1bZeuPbgOLNoJ8Bed5icDukHsoBEQN0DsY8pAAofSbxDoQvb8z5ltydXszO1NnX89NX5F6CDj94PiUOyP5Vs7Gvyd663Lzx8_Mf4Mc-cQ
linkToPdf	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYkCZe-GYEBhgJiQeUNYkT2-GttCtDY9MQTOLNcmwHKrVJla4P40_gr-bOSapGvMFLFMV3kp372b6z74OQN0mpC-aSMkxSkYWpi7JQOluEmY5lIaVz2icwPf0qLr7L6QmmydmW-vJO-6aYH1eL5XE1_-l9K1dLM-r9xEaX5xMhckxpO1rZcrRHbsOcjZLeUO8uEAQYLn2MjOSjNSzDoEqirYShpTLE4nsMV3Cv-u5sST5z_9_r884GNXSe3NmNZvf-Yxz3yd1OBaXjluQBueWqh-TgvLtkf0R-XzU-SJea2lW_bpaOfokjqtdUU9s65gEjxbh9dO1pqK4sXTXIDvY7rUvaYA05PIWj8wqYutStFI986Xg6OUtD3YHCWfpxUS9ds1nUWBv55j3QG9hYaXuX8ZhczU6-TU7DrmRDaDLOrkOY0SbNdMThmYuSpbZ0LC65EPBqAC86B3TIUvC8LJIyN9bFJo-gqXScMcOekP2qrtxTQg3YWkleCG7xJjeJ8tKYVFohY64ja7OAvOulplZtZg7lLRrJVStuBeJWXtxKBOQDCnZLiVm1_Ye6-aE6magiYxwDkSVnOjUsLsB81jkDlS3NJM91QN4iLBTOfZC90V0IA3QYs2ipMai7GVaazwNyNKCE326GzT2wVLdmrFWClQxgnBI6-3rbjJzoB1e5euNpQAFn0M-AHLY43A6ph3NAxAChgzEPWwCYPqN4B8Rn_8z5ihxcTmfq86eLs-fkToJ-P3hMJY7I_nWzcS_I3tpuXvop-gfVhUDx
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Urinary+coenzyme+Q10+as+a+diagnostic+biomarker+and+predictor+of+remission+in+a+patient+with+ADCK4-associated+Glomerulopathy%3A+a+case+report&rft.jtitle=BMC+nephrology&rft.au=Zhang%2C+Yan&rft.au=Liao%2C+Xiaohua&rft.au=Jiang%2C+Yupeng&rft.au=Lv%2C+Xin&rft.date=2021-01-07&rft.pub=BioMed+Central&rft.eissn=1471-2369&rft.volume=22&rft.spage=1&rft_id=info:doi/10.1186%2Fs12882-020-02208-7
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2369&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2369&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2369&client=summon